Oci NV OCI N.V. ORD SHS/ NL0010558797 /
| 2024-05-24 6:37:55 PM | Chg. - | Volume | Bid5:40:12 PM | Ask5:40:12 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 25.87EUR | - | 140,407 Turnover: 334,902.20 |
-Bid Size: - | -Ask Size: - | 2.25 bill.EUR | - | - |
Newsfile Corp
12-21
LILM DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Lilium N.V. Investors with Losses in Exc...
GlobeNewswire
09-03
STMICROELECTRONICS N.V. (NYSE: STM) DEADLINE ALERT: Bernstein Liebhard LLP Reminds STMicroelectronic...
GlobeNewswire
09-03
STM Class Action Alert: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the Class...
GlobeNewswire
08-27
Stockholder Notice: Robbins LLP Informs Stockholders of the Class Action Filed Against STMicroelectr...
GlobeNewswire
08-27
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Stellantis N.V. Investors to Secure Counsel Before Import...
GlobeNewswire
08-26
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of STMicroelectronic...
GlobeNewswire
08-23
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Stellantis N.V. Investors to Secure Counsel Be...
GlobeNewswire
08-01
Merus Announces Financial Results for the Second Quarter 2024 and Provides Business Update
GlobeNewswire
07-24
Merus Announces First Patient Dosed in LiGeR-HN2, a Phase 3 Trial Evaluating Petosemtamab in 2/3L r/...
GlobeNewswire
06-03
Merus’ MCLA-129 Demonstrates Promising Single-Agent Efficiency in METex14 NSCLC in Poster Presentati...
GlobeNewswire
06-02
Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 202...
GlobeNewswire
05-29
Merus to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference
GlobeNewswire
05-28
Merus’ Petosemtamab in Combination with Pembrolizumab Interim Data Demonstrates Robust Response Rate...
GlobeNewswire
05-23
Merus Announces Publication of Abstracts for Presentation at the 2024 ASCO® Annual Meeting
